0001762303 2026-06-03 2026-06-03 true 0001762303 8-K/A 2026-06-03 AVITA Medical, Inc. DE 001-39059 85-1021707 28159 Avenue Stanford Suite 220 Valencia CA 91355 661 367-9170 false false false false Common Stock, par value $0.0001 per share RCEL NASDAQ false This Current Report on Form 8-K/A (this "Amendment") amends the Current Report on Form 8-K filed by AVITA Medical, Inc. (the "Company") with the Securities and Exchange Commission on June 4, 2026 (the "Original Form 8-K"), which reported, among other things, the voting results of the Company's Annual Meeting of Stockholders held on June 3, 2026 (the "Meeting"). The sole purpose of this Amendment is to disclose, in accordance with Item 5.07(d) of Form 8-K, the Company’s decision regarding how frequently it will conduct future stockholder advisory votes to approve the compensation of the Company’s named executive officers. No other changes have been made to the Original Form 8-K.